Molecular Templates (MTEM) - Earnings growth forecast for next year

Brandmark of Molecular Templates Corp (MTEM)

The battle for capital in the high-risk toxins segment led to a sharp surge in expectations, which the linear chart on GURU.Markets reflects through the projected growth of earnings per share for the next fiscal year. Subsequent alliances with pharma behemoths accelerated the development of biologics, but the suspension of tests and asset liquidation wiped out cash flows. Currently, 0.00 forms the current metric value during the structure's closing phase for Molecular Templates (MTEM).

MTEM - Molecular Templates Inc Projected earnings per share increase next year over the range 07/04/2022 - 12/28/2024

Metric breakdowns and analytics for Molecular Templates Inc (MTEM)

- price and consensus price forecast:
Price Chart Molecular Templates|MTEM - Price Target Chart
- market capitalization indicators:
Market Capitalization Molecular Templates, Inc.|MTEM - Enterprise Value
- book capitalization indicators:
Accounting Value per Share Molecular Templates|MTEM - Total Net Assets|Market Capitalization to Book Value Ratio mtem.com|MTEM - Total Asset Value of Company
- debt and liquidity details:
Debt to Equity Molecular Templates|MTEM - Long-Term Liabilities to Capital|Short-Term Debt to Equity Molecular Templates Corp|MTEM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Molecular Templates Corp|MTEM - Company Long-Term Liabilities|Company Short-Term Debt Molecular Templates|Quick Liquidity mtem.com
- earnings and market ratios statistics:
MTEM - Net Income|Expected Profit Molecular Templates|MTEM - Market Cap to Earnings|Future Price to Earnings Molecular Templates, Inc.|MTEM - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Molecular Templates|MTEM - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Molecular Templates|MTEM - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months mtem.com|MTEM - Earnings growth in current year|Net earnings per share growth forecast for next year Molecular Templates
- sales volume and revenue information:
MTEM - Company Revenue|Projected Sales Volume Molecular Templates Corporation|MTEM - P/S Multiple|Price-to-Projected Revenue Ratio Molecular Templates Corp
Fundamental company valuation:MTEM, mtem.com
Core merchandise of Molecular Templates, Inc.

This indicator tracks the dynamics of consensus forecasts for annual profit changes, allowing investors to separate short-term volatility from sustainable fundamental trends. By analyzing the forward net profit growth rate estimates on the GURU.Markets platform, one can assess market expectations for the commercialization of innovative anti-cancer toxins from Molecular Templates (MTEM), where future returns depend directly on the precision of cancer cell targeting.

Analysis of competing companies

Net earnings per share growth forecast for next year Geron Corporation|Net earnings per share growth forecast for next year NBTX|Earnings growth forecast for next year BCYC|Earnings growth forecast for next year CytomX Therapeutics Inc (CTMX)|Perspective Therapeutics, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year GNLX (Genelux Corp)|Molecular Partners AG - Earnings growth forecast for next year|Net earnings per share change forecast for next year ONCY|lisata.com (LSTA) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Moleculin (MBRX)|Net earnings per share growth forecast for next year galeratx.com